Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

A new way in treatment of Benign Prostatic Hyperplasia

Released on = January 11, 2006, 6:23 am

Press Release Author = Joe Mancuso

Industry = Healthcare

Press Release Summary = Serenoa repens known as saw palmetto has become enormous popular in the United States. But many people ask if there is another way to treat BPH. Maybe the featured clinical research gives an answer.

Press Release Body = A new way in treatment of Benign Prostatic Hyperplasia ?
Serenoa repens known as saw palmetto has become enormous popular in the United
States and it is the fifth top-selling herbal medicine on the market, according to a
survey by Whole Foods magazine. In Europe, medical doctors for years have prescribed
Saw Palmetto and other phytomedicines to treat mild to moderate cases of BPH. Today
in Germany alone, the sale of BPH products total 90 percent of sales which are using
Saw Palmetto as their number one source. So many people ask if there is another
alternative way. Lets look what G.Popa et al. have found in their clinical research
in April 2005.

G.Popa,H.Hägele-Kaddour,C.Walther
Efficacy of a Combined Sabal-Urtica Preparation in the Symptomatic Treatment of
Benign Prostatic Hyperplasia.
Results of a Placebo-controlled Double-blind Study
This re-evaluation of a double-blind placebo-controlled therapeutic study of the
combined sabal-urtica preparation PRO 160/120 investigates the
changes in the irritative symptoms of benign prostatic hyperplasia (BPH) under the
test substance in comparison with placebo.It was found that,over the study period of
24 weeks,the micturition symptoms frequency and urgency were statistically
significantly improved under the well-tolerated PRO 160/120 in comparison with
placebo.
The patient 's quality of life was also significantly better under PRO 160/120 in
comparison with placebo.
So G.Popa, who is a urologist, and his team comes to the conclusion that the often
distressing symptoms of BPH can be effectively ameliorated already after only a few
weeks of treatment with the sabal-urtica preparation PRO 160/120. In particular
those patients with the stigmatizing symptoms urinary urgency and frequency benefit
from such treatment.

Maybe this could be a relief for people suffering from BPH. More than 50% of men
older than fifty are affected by an enlargement of the prostate gland. Cause of that
fact alone anyone could realize how important this topic is for mankind.

Read more about BPH on www.sawpalmetto-site.info

Web Site = http://www.sawpalmetto-site.info

Contact Details = Joe Mancuso||Schreiberweg 50||Vienna ,
1190||$$country||||004318413378||agencyhelp@yahoo.de||http://www.sawpalmetto-site.info

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •